IVD Raw Material Market worth $31.1 billion by 2031
The report "IVD Raw Material Market by Product Type (Proteins, Beads, Particles, Antibodies), Technology (Immunoassay, Hematology), Application (Infectious Disease, Diabetes), Supply Source, Origin (Biological, Synthetic), End User (CROs) - Global Forecast to 2031", is projected to grow from USD 21.5 billion in 2026 and to reach USD 31.1 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 7.7% during the forecast period.
Browse 300 market data Tables and 51 Figures spread through 350 Pages and in-depth TOC on "IVD Raw Material Market by Product Type (Proteins, Beads, Particles, Antibodies), Technology (Immunoassay, Hematology), Application (Infectious Disease, Diabetes), Supply Source, Origin (Biological, Synthetic), End User (CROs) - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/ivd-raw-materials-market-60286372.html
The IVD raw material market is experiencing significant growth, largely driven by the increasing global burden of chronic and infectious diseases, which is creating sustained demand for advanced diagnostic testing. Additionally, the growing adoption of molecular diagnostics, immunoassays, and point-of-care testing is further supporting market expansion. Rising investments in diagnostic infrastructure in emerging economies, increasing awareness of early disease detection, and the growing focus on personalized medicine are also accelerating demand for high-quality IVD raw materials among diagnostic manufacturers and healthcare providers.
The antibodies segment accounted for the largest share of the IVD raw material market in 2025.
Based on product type, the IVD raw material market is segmented into antibodies, antigens & proteins, enzymes & substrates, oligonucleotides & nucleic acids, beads & particles, membranes, labels & detection materials, buffers & diluents, and others. The antibodies segment accounted for the largest share of the IVD raw material market in 2025. Antibodies are critical components of a wide range of diagnostic technologies, particularly immunoassays, where they are used to detect and quantify disease-specific biomarkers. Their dominant share reflects their extensive use in infectious disease testing, oncology, cardiac marker testing, autoimmune disease diagnostics, and other clinical applications. The increasing demand for accurate, sensitive, and rapid diagnostic tests, coupled with the growing adoption of automated immunoassay platforms, is expected to sustain the segment’s leading position throughout the forecast period.
The point-of-care testing segment is projected to register the highest CAGR in the IVD raw material market during the forecast period.
The IVD raw material market, by technology, is segmented into immunoassay, molecular diagnostics, clinical chemistry, hematology, microbiology & culture, coagulation, point-of-care testing, flow cytometry, and others. The point-of-care testing segment is expected to experience the highest growth during the forecast period, driven by rising demand for rapid, decentralized, and user-friendly diagnostic solutions. The growing adoption of lateral flow assays, portable diagnostic devices, and near-patient testing is fueling demand for specialized raw materials such as antibodies, antigens, membranes, labels, and detection reagents. Furthermore, increasing healthcare accessibility, rising demand for early disease diagnosis, and ongoing advancements in rapid diagnostic technologies are accelerating the adoption of point-of-care testing solutions, thereby driving strong growth in the segment.
The Asia Pacific is expected to register the highest growth rate in the IVD raw material market during the forecast period.
The IVD raw material market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific is projected to grow at the highest CAGR from 2026 to 2031. China, Japan, and India are the primary growth markets within the region. China's expanding diagnostic manufacturing sector and increasing investments in biotechnology are driving demand for high-quality IVD raw materials. Japan's advanced healthcare system, aging population, and strong focus on precision medicine continue to support the adoption of advanced diagnostic technologies. India's rapidly growing diagnostic industry, expanding laboratory network, and increasing use of molecular diagnostics and point-of-care testing are further contributing to market growth. North America held the largest regional share in 2025, supported by its well-established diagnostics industry, strong presence of leading IVD manufacturers, advanced healthcare infrastructure, and continuous investments in diagnostic innovation.
The major market players covered in the report include Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), Medix Biochemica (Finland), Bio-Techne Corporation (US), Fapon Biotech Inc. (China), Meridian Bioscience, Inc. (US), BBI Solutions (UK), Toyobo Co., Ltd. (Japan), Roche CustomBiotech (Switzerland), Integrated DNA Technologies, Inc. (US), Cytiva (US), Sartorius AG (Germany), LGC Biosearch Technologies (US), Fitzgerald Industries International (US), and Bangs Laboratories, Inc. (US).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the IVD Raw Material Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
